Cannabidiol as an anti-arrhythmic, the role of the CB1 receptors

Author(s): C Y Hepburn, S K Walsh, C L Wainwright

The Robert Gordon University, School of Pharmacy and Life Sciences, Aberdeen, UK

Subject: Heart Disease View the study


Cannabidiol (CBD) has been shown to be anti-arrhythmic (Walsh et al, 2010) and tissue sparing (Durst et al, 2007) in an in vivo rat model of coronary artery occlusion (CAO), although the receptors through which this occurs have yet to be identified. This study was designed to investigate whether the antiarrhythmic effects of CBD are modified by co-administration with a CB1 receptor antagonist (AM251).

Source: BMJ Publishing Group Limited (Price: $37)
Share Tweet

More medical studies related to Heart Disease:

View all medical studies >>

Subscribe for daily cannabis news, announcements, and business insights.

читайте здесь